GlassScriptPhysician profile
Evin Guilliams
NPI 1497287734
$5,264.12
in general payments reported to CMS, 2019-2025
18 companies · $874 in 2025
The $874 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.90 · 2021: $11.04 · 2022: $460 · 2023: $606 · 2024: $3,265 · 2025: $874.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,140 · Travel and Lodging: $1,605.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,139.82 |
| Travel and Lodging | $1,605.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $3,095.43 | 2023-2025 | |
| Depuy Synthes Sales INC. | $708.37 | 2024-2025 | Acis, Embotrap, Trufill |
| Medtronic, INC. | $546.52 | 2021-2025 | Intellis Adaptivestim, Solitaire X, Pipeline |
| Stryker Corporation | $207.73 | 2022-2025 | Direct Inject, Adherus Autospray Dural Sealant |
| Biogen, INC. | $135.05 | 2025 | Vumerity, Tysabri, Leqembi |
| Boston Scientific Corporation | $134.61 | 2019-2025 | General - Therapies, Wavewriter Alpha Prime 16 |
| Djo, LLC | $131.01 | 2025 | Cmf |
| Argenx US, INC. | $76.21 | 2025 | Vyvgart Hytrulo |
| Teva Pharmaceuticals USA, INC. | $41.63 | 2025 | Austedo Xr |
| Integra Lifesciences Corporation | $32.91 | 2022 | |
| Ethicon US, LLC | $31.17 | 2025 | Stratafix, Dermabond Prineo, Surgiflo Hemostatic Matrix |
| Csl Behring | $27.12 | 2024 | Kcentra |
| Neurocrine Biosciences, INC. | $18.85 | 2025 | |
| Convatec INC. | $16.96 | 2025 | |
| Ebi, LLC | $16.92 | 2025 | Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $15.97 | 2025 | Hyqvia |
| Janssen Pharmaceuticals, INC | $14.22 | 2024 | Xarelto |
| Spineology INC. | $13.44 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Evin Guilliams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.